BioSpace News Archive

Blue Ocean Robotics Wins International Top Award

Danish manufacturer of service robots for the healthcare, hospitality, construction and agricultural sectors, Blue Ocean Robotics, wins one of the most prestigious awards in the robotics industry, the IERA Award 2019.

May 23, 2019
·
2 min read
Drug Development

Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint

The partner of CStone Pharmaceuticals, Agios Pharmaceuticals, Inc. announced that the global Phase 3 ClarIDHy trial of TIBSOVO in previously treated cholangiocarcinoma patients with an isocitrate dehydrogenase 1 (IDH1) mutation met its primary endpoint.

May 23, 2019
·
4 min read
Rapid Multiplexing with Opal® Research Kits Now Available on LabSat™ Platform

Lunaphore Technologies S.A., a Swiss medtech firm developing innovative next-generation equipment for cancer research and tissue diagnostics, announces a new rapid multiplexing application for its LabSat™ Research instrument

May 23, 2019
·
4 min read
Genetown

Corindus CorPath GRX System Successfully Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France

May 23, 2019
·
6 min read
Business

Lannett Appoints Melissa V. Rewolinski, PhD, To Board Of Directors

Lannett Company, Inc. announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019.

May 23, 2019
·
2 min read
Job Trends

Initial Study of the Minimally Invasive RheOx™ Device Demonstrates Positive Results for Chronic Bronchitis Patients

Gala Therapeutics, Inc. announced new results from the initial study of its investigational RheOxTM device, demonstrating the safety and feasibility of Bronchial RheoplastyTM therapy to provide clinical benefit to patients with chronic bronchitis.

May 23, 2019
·
3 min read
Drug Development

Immunovant Initiates Dosing in ASCEND-GO 1, a Phase 2a Trial of IMVT-1401 in Patients with Graves’ Ophthalmopathy (GO)

Immunovant, a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients living with debilitating autoimmune diseases, today announced that it has initiated dosing in ASCEND-GO 1, an open label, single-arm Phase 2a clinical trial evaluating IMVT-1401 in patients with moderate-to-severe active Graves’ ophthalmopathy

May 23, 2019
·
4 min read
Business

Analytical Graphics and ANSYS Launch Joint Technology Partnership

Strategic agreement leverages physics-based models to deliver mission simulations with unparalleled accuracy and reliability

May 23, 2019
·
3 min read
Deals

InDemand Interpreting Acquired by Stratus Video

InDemand Interpreting, a portfolio company of Health Enterprise Partners, announced its acquisition by Stratus Video, LLC, a portfolio company of Kinderhook, LLC.

May 23, 2019
·
3 min read
Deals

BlueRock Therapeutics to Participate at Upcoming Conferences - May 23, 2019

BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel CELL+GENE™ platform to develop regenerative medicines for intractable diseases, announced that the company will present at the following upcoming conferences.

May 23, 2019
·
1 min read